CareDx, Inc.

Ticker: CDNA

Class Period Start: 02/24/2021

Class Period End: 05/05/2022

Registration Deadline: 07/22/2022

A securities class action has been filed in the USDC, N.D.CA. against CareDx, Inc. (CDNA) on behalf of all persons or entities who purchased CareDx common stock between February 24, 2021 through May 5, 2022.

CareDx is a diagnostics company that provides services and products to the organ transplant recipient community, offering diagnostic testing services, products, and digital healthcare software for transplant patients and care providers. The information gathered through the Company’s surveillance and tests purportedly enables clinicians to make treatment decisions in the event of signs of organ rejection.

The Complaint alleges that throughout the Class Period, Defendants had engaged in a variety of improper and illegal schemes to inflate testing services revenue, including:

  • pushing protocols for surveillance of organ rejection through inaccurate marketing materials and in violation of Medicare standards;
  • offering extravagant inducements or kickbacks to physicians and other providers; and
  • improperly bundling expensive testing services with other blood tests as part of the RemoTraC service. These practices, and others, subjected CareDx to an undisclosed risk of regulatory scrutiny and rendered the Company’s testing services revenue and demand reported throughout the Class Period artificially inflated. As a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

If you suffered a loss on your investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Purchases

Sales

Please Note

Neither the submission to nor the receipt of information by Lowey Dannenberg or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* Indicates a required field.

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.